COGT Cogent Biosciences Inc

Nobody is talking about three FDA clocks on one molecule and I like that part imo $COGT Nov 30 comes first, 42 days out. bezuclastinib plus sunitinib in GIST after imatinib, Priority Review, PEAK showed median PFS 16.5 months vs 9.2 with a hazard ratio of 0.50 FDA said at acceptance no advisory committee planned and no review issues flagged. Dec 30 is next, then June 29. a yes Nov 30 gives Cogent its first approved drug, trading around 30 today

$COGT Cantor Investor Survey 90 participants was the Top M&A pic mentioned the most. Sometimes, everyone knows and its obvious. Doesn't happen often but it's time for bios to throw us a bone..

30 days out and $COGT still reads like three clocks on one molecule imo Nov 30 comes first, bezuclastinib plus sunitinib in GIST after imatinib, Priority Review, no advisory committee planned PEAK did 16.5 months median PFS vs 9.2 on sunitinib alone. Dec 30 is next, and the room still talks like Nov 30 is the only date

$COGT this week’s Biotech report just dropped. Cogent is one of the names discussed along with 9 other setups as we go deeper into Q4 $XBI

39 days out and $COGT still gets treated like a single binary name imo Nov 30 PDUFA, Priority Review, bezuclastinib plus sunitinib in GIST after imatinib PEAK did 16.5 months median PFS vs 9.2 on sunitinib alone, hazard ratio 0.50, and FDA said no advisory committee planned trading near 30.96 today, down about 1.5 percent off a 31.43 close, up about 10 percent in 5 sessions that is the first of three dates for the same molecule ngl

$COGT down to $30, good example of high-quality names that get thrown out with the bathwater (or at least dragged down)

$COGT three wave measured move pullback to the Fib .382 retracement level, with bullish divergences on the technical indicators